申请人:Robichaud J. Albert
公开号:US20060178362A1
公开(公告)日:2006-08-10
The present invention is directed to compounds useful for treating addictive behavior and sleep disorders represented by structural Formula (I)
or pharmaceutically acceptable salt forms thereof, wherein R
1
, R
5
, R
6a
, R
6b
, R
7
, R
8
, R
9
, X, b, k, m, and n, and the dashed lines are described herein. The compounds used in the method of treatment of this invention are serotonin agonists and antagonists and are useful in the control or prevention of central nervous system disorders including addictive behavior and sleep disorders.
本发明涉及用于治疗成瘾行为和睡眠障碍的化合物,其结构式表示为(I),或其药学上可接受的盐形式,其中R1、R5、R6a、R6b、R7、R8、R9、X、b、k、m和n以及虚线如本文所述。本发明方法中使用的化合物是5-羟色胺激动剂和拮抗剂,并且对于控制或预防包括成瘾行为和睡眠障碍在内的中枢神经系统疾病是有用的。